LAVA Therapeutics NV (LVTX) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

LVTX ratio: 57%

100%

LVTX beat 8 of 14 last estimates

Date of next report: Nov 21, 2024

Estimate for Q3 24: $-0.34

Implied change from Q2 24: +9.68%

Implied change from Q3 23: 0.00%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q2 24	Aug 20, 2024	$-0.31 / $-0.33	$0.02 / 6.06%
Q1 24	May 21, 2024	$-0.02 / $-0.25	$0.23 / 92%
Q4 23	Mar 20, 2024	$-0.24 / $0.16	$-0.4 / -250%
Q3 23	Nov 16, 2023	$-0.34 / $-0.48	$0.14 / 29.17%
Q2 23	Aug 22, 2023	$-0.48 / $-0.48	$0 / -
Q1 23	Jun 8, 2023	$-0.53 / $-0.47	$-0.06 / -12.77%
Q4 22	Apr 11, 2023	$-0.57 / $-	$0 / -
Q3 22	Nov 16, 2022	$0.04 / $-0.07	$0.11 / 157.14%

Data Vendor: Xignite Logo